Annual Operating Profit
-$142.04 M
-$34.95 M-32.63%
31 December 2023
Summary:
Celldex Therapeutics annual operaing income is currently -$142.04 million, with the most recent change of -$34.95 million (-32.63%) on 31 December 2023. During the last 3 years, it has fallen by -$92.47 million (-186.54%). CLDX annual operating profit is now -8777.63% below its all-time high of -$1.60 million, reached on 30 April 1987.CLDX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$52.13 M
-$5.81 M-12.54%
01 September 2024
Summary:
Celldex Therapeutics quarterly operating income is currently -$52.13 million, with the most recent change of -$5.81 million (-12.54%) on 01 September 2024. Over the past year, it has dropped by -$10.89 million (-26.40%). CLDX quarterly operating profit is now -346.27% below its all-time high of $21.17 million, reached on 31 December 2010.CLDX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$174.18 M
-$10.89 M-6.67%
01 September 2024
Summary:
Celldex Therapeutics TTM operating income is currently -$174.18 million, with the most recent change of -$10.89 million (-6.67%) on 01 September 2024. Over the past year, it has dropped by -$39.38 million (-29.21%). CLDX TTM operating profit is now -4058.59% below its all-time high of $4.40 million, reached on 30 April 1990.CLDX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -32.6% | -26.4% | -29.2% |
| 3 y3 years | -186.5% | -171.1% | -196.1% |
| 5 y5 years | -85.9% | -273.4% | -213.1% |
CLDX Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -186.5% | at low | -171.1% | at low | -196.1% | at low |
| 5 y | 5 years | -186.5% | at low | -407.9% | at low | -251.4% | at low |
| alltime | all time | -8777.6% | at low | -346.3% | at low | -4058.6% | at low |
Celldex Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$52.13 M(+12.5%) | -$174.18 M(+6.7%) |
| June 2024 | - | -$46.32 M(+14.1%) | -$163.29 M(+8.7%) |
| Mar 2024 | - | -$40.61 M(+15.6%) | -$150.18 M(+5.7%) |
| Dec 2023 | -$142.04 M(+32.6%) | -$35.13 M(-14.8%) | -$142.04 M(+5.4%) |
| Sept 2023 | - | -$41.24 M(+24.2%) | -$134.80 M(+11.2%) |
| June 2023 | - | -$33.20 M(+2.3%) | -$121.26 M(+4.7%) |
| Mar 2023 | - | -$32.47 M(+16.4%) | -$115.77 M(+8.1%) |
| Dec 2022 | -$107.10 M(+54.9%) | -$27.89 M(+0.7%) | -$107.10 M(+7.3%) |
| Sept 2022 | - | -$27.70 M(-0.1%) | -$99.80 M(+9.3%) |
| June 2022 | - | -$27.72 M(+16.5%) | -$91.33 M(+18.9%) |
| Mar 2022 | - | -$23.79 M(+15.6%) | -$76.78 M(+11.0%) |
| Dec 2021 | -$69.15 M(+39.5%) | -$20.59 M(+7.1%) | -$69.15 M(+17.5%) |
| Sept 2021 | - | -$19.23 M(+45.8%) | -$58.83 M(+10.4%) |
| June 2021 | - | -$13.18 M(-18.4%) | -$53.28 M(+0.3%) |
| Mar 2021 | - | -$16.16 M(+57.4%) | -$53.10 M(+7.1%) |
| Dec 2020 | -$49.57 M(-9.1%) | -$10.26 M(-25.0%) | -$49.57 M(-4.6%) |
| Sept 2020 | - | -$13.68 M(+5.3%) | -$51.98 M(-0.5%) |
| June 2020 | - | -$13.00 M(+2.9%) | -$52.26 M(-0.5%) |
| Mar 2020 | - | -$12.63 M(-0.3%) | -$52.54 M(-3.6%) |
| Dec 2019 | -$54.52 M(-28.6%) | -$12.67 M(-9.2%) | -$54.52 M(-2.0%) |
| Sept 2019 | - | -$13.96 M(+5.2%) | -$55.63 M(-1.3%) |
| June 2019 | - | -$13.27 M(-9.2%) | -$56.37 M(-16.4%) |
| Mar 2019 | - | -$14.62 M(+6.1%) | -$67.40 M(-11.8%) |
| Dec 2018 | -$76.40 M(-30.1%) | -$13.78 M(-6.3%) | -$76.41 M(-13.9%) |
| Sept 2018 | - | -$14.70 M(-39.5%) | -$88.75 M(-9.1%) |
| June 2018 | - | -$24.31 M(+2.9%) | -$97.62 M(-3.6%) |
| Mar 2018 | - | -$23.62 M(-9.6%) | -$101.24 M(-7.4%) |
| Dec 2017 | -$109.33 M(-17.7%) | -$26.13 M(+10.9%) | -$109.33 M(-7.4%) |
| Sept 2017 | - | -$23.56 M(-15.6%) | -$118.05 M(-5.2%) |
| June 2017 | - | -$27.93 M(-11.9%) | -$124.48 M(-3.4%) |
| Mar 2017 | - | -$31.71 M(-9.0%) | -$128.92 M(-3.0%) |
| Dec 2016 | -$132.92 M(+2.6%) | -$34.85 M(+16.2%) | -$132.91 M(+1.1%) |
| Sept 2016 | - | -$29.99 M(-7.3%) | -$131.50 M(-1.8%) |
| June 2016 | - | -$32.37 M(-9.3%) | -$133.88 M(-0.3%) |
| Mar 2016 | - | -$35.70 M(+6.8%) | -$134.26 M(+3.6%) |
| Dec 2015 | -$129.54 M(+5.8%) | -$33.44 M(+3.3%) | -$129.54 M(+1.1%) |
| Sept 2015 | - | -$32.37 M(-1.2%) | -$128.15 M(+1.6%) |
| June 2015 | - | -$32.75 M(+5.7%) | -$126.12 M(+3.4%) |
| Mar 2015 | - | -$30.98 M(-3.3%) | -$121.92 M(-0.4%) |
| Dec 2014 | -$122.43 M(+50.3%) | -$32.05 M(+5.6%) | -$122.43 M(+8.8%) |
| Sept 2014 | - | -$30.34 M(+6.3%) | -$112.49 M(+6.7%) |
| June 2014 | - | -$28.55 M(-9.3%) | -$105.42 M(+10.4%) |
| Mar 2014 | - | -$31.49 M(+42.4%) | -$95.53 M(+17.3%) |
| Dec 2013 | -$81.44 M(+40.2%) | -$22.11 M(-5.0%) | -$81.44 M(+7.3%) |
| Sept 2013 | - | -$23.27 M(+24.7%) | -$75.88 M(+12.6%) |
| June 2013 | - | -$18.66 M(+7.2%) | -$67.36 M(+8.3%) |
| Mar 2013 | - | -$17.40 M(+5.1%) | -$62.19 M(+7.1%) |
| Dec 2012 | -$58.08 M(+33.8%) | -$16.55 M(+12.2%) | -$58.08 M(+7.7%) |
| Sept 2012 | - | -$14.75 M(+9.4%) | -$53.91 M(+6.5%) |
| June 2012 | - | -$13.49 M(+1.5%) | -$50.64 M(+7.7%) |
| Mar 2012 | - | -$13.29 M(+7.3%) | -$47.03 M(+8.4%) |
| Dec 2011 | -$43.40 M(+572.3%) | -$12.38 M(+7.9%) | -$43.40 M(+340.6%) |
| Sept 2011 | - | -$11.48 M(+16.2%) | -$9.85 M(+34.9%) |
| June 2011 | - | -$9.88 M(+2.3%) | -$7.30 M(+8.9%) |
| Mar 2011 | - | -$9.66 M(-145.6%) | -$6.71 M(+3.9%) |
| Dec 2010 | -$6.46 M(-82.8%) | $21.17 M(-337.0%) | -$6.46 M(-84.4%) |
| Sept 2010 | - | -$8.93 M(-3.8%) | -$41.41 M(+4.5%) |
| June 2010 | - | -$9.29 M(-1.3%) | -$39.64 M(+1.4%) |
| Mar 2010 | - | -$9.41 M(-31.8%) | -$39.08 M(+4.3%) |
| Dec 2009 | -$37.45 M(+10.2%) | -$13.79 M(+92.7%) | -$37.45 M(+19.6%) |
| Sept 2009 | - | -$7.16 M(-18.0%) | -$31.31 M(-4.3%) |
| June 2009 | - | -$8.72 M(+12.0%) | -$32.73 M(-4.8%) |
| Mar 2009 | - | -$7.79 M(+1.9%) | -$34.37 M(+1.1%) |
| Dec 2008 | -$34.00 M(+119.2%) | -$7.64 M(-10.9%) | -$34.00 M(+10.9%) |
| Sept 2008 | - | -$8.58 M(-17.2%) | -$30.65 M(+16.8%) |
| June 2008 | - | -$10.36 M(+39.6%) | -$26.25 M(+40.2%) |
| Mar 2008 | - | -$7.42 M(+73.0%) | -$18.73 M(+20.7%) |
| Dec 2007 | -$15.51 M(-17.5%) | -$4.29 M(+2.7%) | -$15.51 M(+5.7%) |
| Sept 2007 | - | -$4.18 M(+47.1%) | -$14.67 M(-11.8%) |
| June 2007 | - | -$2.84 M(-32.4%) | -$16.63 M(-17.3%) |
| Mar 2007 | - | -$4.20 M(+22.0%) | -$20.12 M(+7.0%) |
| Dec 2006 | -$18.79 M(-0.4%) | -$3.45 M(-43.9%) | -$18.79 M(-4.2%) |
| Sept 2006 | - | -$6.14 M(-2.8%) | -$19.63 M(+8.2%) |
| June 2006 | - | -$6.32 M(+119.6%) | -$18.15 M(+8.5%) |
| Mar 2006 | - | -$2.88 M(-32.7%) | -$16.72 M(-11.3%) |
| Dec 2005 | -$18.86 M(+38.9%) | -$4.28 M(-8.3%) | -$18.86 M(+2.6%) |
| Sept 2005 | - | -$4.66 M(-4.9%) | -$18.40 M(+4.8%) |
| June 2005 | - | -$4.90 M(-2.3%) | -$17.55 M(+5.5%) |
| Mar 2005 | - | -$5.02 M(+31.8%) | -$16.64 M(+22.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2004 | -$13.58 M(+15.8%) | -$3.81 M(-0.3%) | -$13.58 M(+7.3%) |
| Sept 2004 | - | -$3.82 M(-4.4%) | -$12.66 M(+15.0%) |
| June 2004 | - | -$3.99 M(+103.4%) | -$11.01 M(+7.8%) |
| Mar 2004 | - | -$1.96 M(-32.0%) | -$10.21 M(-13.0%) |
| Dec 2003 | -$11.73 M(-18.7%) | -$2.89 M(+33.2%) | -$11.73 M(-5.7%) |
| Sept 2003 | - | -$2.17 M(-32.2%) | -$12.44 M(+16.6%) |
| June 2003 | - | -$3.20 M(-8.3%) | -$10.67 M(-16.7%) |
| Mar 2003 | - | -$3.48 M(-3.0%) | -$12.80 M(-11.3%) |
| Dec 2002 | -$14.43 M(-41.2%) | -$3.59 M(+803.2%) | -$14.43 M(-19.7%) |
| Sept 2002 | - | -$397.50 K(-92.5%) | -$17.97 M(-25.6%) |
| June 2002 | - | -$5.33 M(+4.1%) | -$24.15 M(-3.3%) |
| Mar 2002 | - | -$5.12 M(-28.2%) | -$24.98 M(+1.8%) |
| Dec 2001 | -$24.56 M(+59.1%) | -$7.13 M(+8.3%) | -$24.55 M(+8.4%) |
| Sept 2001 | - | -$6.58 M(+6.9%) | -$22.65 M(+11.1%) |
| June 2001 | - | -$6.16 M(+31.4%) | -$20.39 M(+18.4%) |
| Mar 2001 | - | -$4.69 M(-10.3%) | -$17.22 M(+11.5%) |
| Dec 2000 | -$15.44 M(+29.3%) | -$5.22 M(+20.7%) | -$15.44 M(+9.0%) |
| Sept 2000 | - | -$4.33 M(+44.8%) | -$14.16 M(+13.0%) |
| June 2000 | - | -$2.99 M(+2.9%) | -$12.54 M(+4.5%) |
| Mar 2000 | - | -$2.90 M(-26.4%) | -$12.00 M(-0.8%) |
| Dec 1999 | -$11.94 M(+50.3%) | -$3.94 M(+46.1%) | -$12.10 M(+13.0%) |
| Sept 1999 | - | -$2.70 M(+10.1%) | -$10.70 M(+3.9%) |
| June 1999 | - | -$2.45 M(-18.3%) | -$10.30 M(+9.0%) |
| Mar 1999 | - | -$3.00 M(+17.7%) | -$9.45 M(+18.9%) |
| Dec 1998 | -$7.95 M(+3.1%) | -$2.55 M(+10.9%) | -$7.95 M(+11.8%) |
| Sept 1998 | - | -$2.30 M(+43.8%) | -$7.11 M(+2.9%) |
| June 1998 | - | -$1.60 M(+6.7%) | -$6.91 M(-4.2%) |
| Mar 1998 | - | -$1.50 M(-12.2%) | -$7.21 M(-6.5%) |
| Dec 1997 | -$7.71 M(-34.7%) | -$1.71 M(-18.7%) | -$7.71 M(-11.4%) |
| Sept 1997 | - | -$2.10 M(+10.5%) | -$8.70 M(-2.2%) |
| June 1997 | - | -$1.90 M(-5.0%) | -$8.90 M(-21.9%) |
| Mar 1997 | - | -$2.00 M(-25.9%) | -$11.40 M(-1.7%) |
| Dec 1996 | -$11.80 M(0.0%) | -$2.70 M(+17.4%) | -$11.60 M(-4.1%) |
| Sept 1996 | - | -$2.30 M(-47.7%) | -$12.10 M(-7.6%) |
| June 1996 | - | -$4.40 M(+100.0%) | -$13.10 M(+15.9%) |
| Mar 1996 | - | -$2.20 M(-31.3%) | -$11.30 M(-4.2%) |
| Dec 1995 | -$11.80 M(+24.2%) | -$3.20 M(-3.0%) | -$11.80 M(+9.3%) |
| Sept 1995 | - | -$3.30 M(+26.9%) | -$10.80 M(+8.0%) |
| June 1995 | - | -$2.60 M(-3.7%) | -$10.00 M(0.0%) |
| Mar 1995 | - | -$2.70 M(+22.7%) | -$10.00 M(+4.2%) |
| Dec 1994 | -$9.50 M(+1.1%) | -$2.20 M(-12.0%) | -$9.60 M(-3.0%) |
| Sept 1994 | - | -$2.50 M(-3.8%) | -$9.90 M(-3.9%) |
| June 1994 | - | -$2.60 M(+13.0%) | -$10.30 M(+6.2%) |
| Mar 1994 | - | -$2.30 M(-8.0%) | -$9.70 M(+1.0%) |
| Dec 1993 | -$9.40 M(+100.0%) | -$2.50 M(-13.8%) | -$9.60 M(+35.2%) |
| Sept 1993 | - | -$2.90 M(+45.0%) | -$7.10 M(+26.8%) |
| June 1993 | - | -$2.00 M(-9.1%) | -$5.60 M(+9.8%) |
| Mar 1993 | - | -$2.20 M(+57.1%) | -$5.10 M(-8.9%) |
| Dec 1992 | -$4.70 M(-27.7%) | - | - |
| Oct 1992 | - | -$1.40 M(-6.7%) | -$5.60 M(-11.1%) |
| July 1992 | - | -$1.50 M(-21.1%) | -$6.30 M(-3.1%) |
| Apr 1992 | - | -$1.90 M(+137.5%) | -$6.50 M(+10.2%) |
| Apr 1992 | -$6.50 M(+47.7%) | - | - |
| Jan 1992 | - | -$800.00 K(-61.9%) | -$5.90 M(-3.3%) |
| Oct 1991 | - | -$2.10 M(+23.5%) | -$6.10 M(+22.0%) |
| July 1991 | - | -$1.70 M(+30.8%) | -$5.00 M(+11.1%) |
| Apr 1991 | -$4.40 M(+131.6%) | -$1.30 M(+30.0%) | -$4.50 M(+45.2%) |
| Jan 1991 | - | -$1.00 M(0.0%) | -$3.10 M(+34.8%) |
| Oct 1990 | - | -$1.00 M(-16.7%) | -$2.30 M(-309.1%) |
| July 1990 | - | -$1.20 M(-1300.0%) | $1.10 M(-75.0%) |
| Apr 1990 | -$1.90 M(+18.8%) | $100.00 K(-150.0%) | $4.40 M(-257.1%) |
| Jan 1990 | - | -$200.00 K(-108.3%) | -$2.80 M(+300.0%) |
| Oct 1989 | - | $2.40 M(+14.3%) | -$700.00 K(-41.7%) |
| July 1989 | - | $2.10 M(-129.6%) | -$1.20 M(-25.0%) |
| Apr 1989 | -$1.60 M(-20.0%) | -$7.10 M(-473.7%) | -$1.60 M(+433.3%) |
| Jan 1989 | - | $1.90 M(0.0%) | -$300.00 K(-57.1%) |
| Oct 1988 | - | $1.90 M(+11.8%) | -$700.00 K(-50.0%) |
| July 1988 | - | $1.70 M(-129.3%) | -$1.40 M(-33.3%) |
| Apr 1988 | -$2.00 M(+25.0%) | -$5.80 M(-486.7%) | -$2.10 M(-2200.0%) |
| Jan 1988 | - | $1.50 M(+25.0%) | $100.00 K(-116.7%) |
| Oct 1987 | - | $1.20 M(+20.0%) | -$600.00 K(-50.0%) |
| July 1987 | - | $1.00 M(-127.8%) | -$1.20 M(-40.0%) |
| Apr 1987 | -$1.60 M(-15.8%) | -$3.60 M(-550.0%) | -$2.00 M(+400.0%) |
| Jan 1987 | - | $800.00 K(+33.3%) | -$400.00 K(-63.6%) |
| Oct 1986 | - | $600.00 K(+200.0%) | -$1.10 M(-31.3%) |
| July 1986 | - | $200.00 K(-110.0%) | -$1.60 M(-5.9%) |
| Apr 1986 | -$1.90 M | -$2.00 M(-2100.0%) | -$1.70 M(-666.7%) |
| Jan 1986 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| Oct 1985 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| July 1985 | - | $100.00 K | $100.00 K |
FAQ
- What is Celldex Therapeutics annual operaing income?
- What is the all time high annual operating profit for Celldex Therapeutics?
- What is Celldex Therapeutics annual operating profit year-on-year change?
- What is Celldex Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly operating profit year-on-year change?
- What is Celldex Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Celldex Therapeutics?
- What is Celldex Therapeutics TTM operating profit year-on-year change?
What is Celldex Therapeutics annual operaing income?
The current annual operating profit of CLDX is -$142.04 M
What is the all time high annual operating profit for Celldex Therapeutics?
Celldex Therapeutics all-time high annual operaing income is -$1.60 M
What is Celldex Therapeutics annual operating profit year-on-year change?
Over the past year, CLDX annual operaing income has changed by -$34.95 M (-32.63%)
What is Celldex Therapeutics quarterly operating income?
The current quarterly operating profit of CLDX is -$52.13 M
What is the all time high quarterly operating profit for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly operating income is $21.17 M
What is Celldex Therapeutics quarterly operating profit year-on-year change?
Over the past year, CLDX quarterly operating income has changed by -$10.89 M (-26.40%)
What is Celldex Therapeutics TTM operating income?
The current TTM operating profit of CLDX is -$174.18 M
What is the all time high TTM operating profit for Celldex Therapeutics?
Celldex Therapeutics all-time high TTM operating income is $4.40 M
What is Celldex Therapeutics TTM operating profit year-on-year change?
Over the past year, CLDX TTM operating income has changed by -$39.38 M (-29.21%)